A Vision to be the Best
As the largest group of Retina specialists in the Greater Kansas City, Topeka, Sedalia and surrounding areas we offer multiple professional offices to serve you. Each of our offices are staffed and equipped to provide the highest level of health care service and access in a comfortable environment.
Ryan D. Christensen, M.D.
Dr. Christensen CURRICULUM VITAE
NAME
- Ryan D. Christensen, M.D.
BIRTHDATE
- April 16, 1977; Garden City, Kansas
WORK HISTORY
2010 - PRESENT:
- Retina Associates, P.A.
Santa Fe Medical Building
9301 West 74th Street
Suite 210
Shawnee Mission, KS 66204 - Retina Associates, P.A.
6201 College Boulevard
Suite 200
Overland Park, KS 66211 - Retina Associates. P.A.
10100 N Ambassador Drive
Suite 100
Kansas City, MO 64153 - Retina Associates, P.A.
6001 SW 6th Avenue
Suite 300
Topeka, KS 66615 - Retina Associates, P.A.
3700 W 10th Street
Suite 101
Sedalia, MO 65301 - Retina Associates, P.A.
100 NE Missouri Road
Suite 203
Lee's Summit, MO 64086
EDUCATION:
- Retina Associates, P.A. – Shawnee Mission, KS 2008-2010
-Vitreoretinal Fellowship - University of Kansas School of Medicine – Kansas City, KS 2005-2008
-Ophthalmology residency - University of Kansas School of Medicine – Wichita, KS 2003-2004
-Internal Medicine internship - University of Kansas School of Medicine – Wichita, KS 2002-2004
-Clinical clerkship – medical school - University of Kansas School of Medicine – Kansas City, KS 2000-2002
-Basic science clerkship – medical school - Kansas State University – Manhattan, KS 1995-2000
-Bachelor of Science – Biology - Garden City Community College – Garden City, KS 1996-1997
- Garden City High School – Garden City, KS 1991-1995
RESEARCH:
- Eyetech: EOP1024, Sub-Investigator,
Evaluating the effects of Intravitreal
Injections of Pegaptanib for NVAMD
on the corneal endothelium 2010-present - Genentech: FVF4168g, Sub-Investigator,
Intravitreal Injection of Ranibizumab for
Diabetic Macular Edema 2008-present - Genentech: FVF4166g, Sub-Investigator,
Intravitreal Injection of Ranibizumab for
Central Retinal Vein Occlusion 2008-2010 - Genentech: FVF4165g, Sub-Investigator,
Intravitreal Injection of Ranibizumab for
Branch Retinal Vein Occlusion 2008-2010 - Genentech: FVF3426g, Sub-Investigator,
Intravitreal Injection of Ranibizumab for
BRVO & CRVO patients who completed
Genentech sponsored Ranibizumab Study 2009-2010 - Genentech: FVF4579g, Sub-Investigator,
Intravitreal Injection of Ranibizumab for
Subfoveal Neovascular AMD 2009-present - Genentech: FVF4967g, Sub-Investigator,
Intravitreal Injection of Ranibizumab for
BRVO, CRVO, & HRVO study to start 2/2011 - Ophthotech: OPH3000, Sub-Investigator,
Intravitreal Injection of Volocixumab in
combination with Ranibizumab for NVAMD 2008-2009 - Ophthotech: OPH1001, Sub-Investigator,
Intravitreal Injection of E10030 in
combination with Ranibizumab for NVAMD 2010-present
SCHOLARLY PRESENTATIONS
- “Fluorescein Angiography #101” 2008/09
-KU Eye
-Monthly lecture series - “Posterior Parasitic Uveitis” 11/2007
-KU Eye Grand Rounds - “Parasitic Uveitis: Worm in the Eye!!" 02/2007
-High Plain’s Eye Society Winter Symposium - “Adherence to Preferred Practice Patterns in ARMD” 06/2007
-KU Eye Grand Rounds - “AAO Mid-Year Forum 2007” 06/2007
-KU Eye Grand Rounds - “Orbital Masses – A Differential Diagnosis” 05/2007
-Children’s Mercy Hospital Grand Rounds - "Eyelid Tumors - Clinical Diagnosis and Histology 101" 09/2006
-KU Eye Grand Rounds - "Herpetic Corneal Disorders" 07/2006
-KU Eye New Resident Orientation - "Common Corneal Disorders" 07/2006
-KU Eye New Resident Orientation - "Cogan's Syndrome - Oculovestibuloauditory Syndrome" 06/2006
-KU Eye Resident Research Day - "LASIK and Excimer Laser Evolution" 03/2006
-KU Eye Grand Rounds - "Aceruloplasminemia – Fundus and Fluorescein Angiography" 04/2006
- KU Medical Center Internal Medicine Grand Rounds - "The Red Eye - A Differential Diagnosis" 07/2005
-KU Medical Center Pediatrics Morning Report
